Premas Biotech’s Covid vaccine candidate shows positive results in animal studies

By: |
August 27, 2020 9:26 PM

The company is in talks with the Indian regulatory authorities concerned to plan and initiate next steps towards conducting human trials, Premas Biotech said in a statement.

Multiple companies are developing Covid vaccine in India

Premas Biotech on Thursday said its vaccine candidate for COVID-19 treatment has shown positive results, inducing a neutralising immune response in animal studies. The company is in talks with the Indian regulatory authorities concerned to plan and initiate next steps towards conducting human trials, Premas Biotech said in a statement.

“We are happy to report that the vaccine candidate study in mice has gone on well, and the results are positive and encouraging. We have engaged with the regulatory authorities in India and are working towards the next steps under their guidance,” Premas Biotech Co-Founder and MD Prabuddha Kundu said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1TN makes negative COVID report a must for those from Kerala
2COVID-19: Maha logs 6,126 new cases, 195 deaths; 7,436 recover
3Delhi records zero COVID-19 fatality, fifth time since onset of 2nd wave of pandemic; 67 cases